Should you buy Centene stock now?
The technical signal for Centene is currently NEUTRAL. Centene trades at $63.59 as of 8/6/2026. The overall technical signal is: Hold. The technical analysis shows the following: MACD is negative (bearish trend) at -0.036 with falling momentum (signal: 0.091); RSI is at 57.8 (neutral zone); the stock is in a short-term downtrend (price below the 20-day average); the analyst price target of $71.28 points to 12.1% upside. This is a technical observation based on current data, not investment advice.
What is the price target for Centene stock?
The average analyst price target for Centene is $71.28. The current price is $63.59, which gives an upside of 12.1%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $64.15 and $78.41.
Is Centene a dividend stock?
No, Centene does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of Centene stock?
Centene is rated as a stock with high risk. the annual standard deviation is 49.1%, which classifies the stock as high risk.
Is Centene overvalued?
No, Centene is considered undervalued based on the analyst price target (12.1% upside). Centene has the following valuation ratios: a P/S ratio of 0.2, a P/B ratio of 1.4. The analyst price target suggests that the stock is undervalued by 12.1%.
Is Centene overbought?
No, Centene is not overbought. RSI is at 57.8 (neutral zone). The technical indicators show: RSI is at 57.8 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 2.4% below the 20-day average (short-term downtrend). In addition, MACD is negative with falling momentum (bearish).
When is the next Centene earnings report?
Centene reports its next earnings on October 27, 2026. The stock currently trades at $63.59.
Is Centene shorted?
Yes, Centene is shorted with 3.1% of the free float sold short. This is a moderate level of short selling, within the normal range for most stocks. Data is updated daily based on official filings with the SEC.
Are insiders buying Centene stock?
No, insiders are not buying Centene shares – they are net sellers. Over the last 3 months, insiders have made 0 purchases and 2 sales. On a net basis, 5,195,487 $ worth of shares were sold. Across the last 20 reported transactions, the split is 4 purchases and 16 sales, with a net 9,963,321 $ sold. Active sellers include SMITH SUSAN RAYE, Burdick Kenneth A, MCNALLY TANYA M and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Centene a good stock?
Based on our total score, Centene is rated as a good stock with a total score of 64 out of 100. The stock scores above average on value, quality and momentum – it is among the top 36% in our database. The score is made up of Value: 52/100, Quality: 44/100, Momentum: 96/100. In addition: analysts see 12.1% upside to the price target; technical signal: Hold. Whether Centene is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Centene stock?
The outlook for Centene based on current data: the average analyst price target is $71.28 (+12.1%); the next earnings report is due on 10/27/2026, which can move the price. Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Centene stock falling?
Centene is falling right now. The technical indicators show: the price is 2.4% below the 20-day average; MACD is negative with falling momentum (bearish signal); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis, insider section and news overview above.
How high can Centene go?
The average analyst price target for Centene is $71.28, which corresponds to a potential gain of 12.1% from the current price of $63.59. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Centene fall?
We lack enough history to give a specific floor for Centene. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Centene do?
Centene Corporation er et stort sundhedsselskab, der driver forretning ved at tilbyde sundhedsplaner til folk i USA, som har begrænset forsikring eller ingen forsikring. Deres forretning bygger primært på statsstøttede programmer som Medicaid og programmer for børn.
De tjener... The company belongs to the Sundhed sector, more specifically the Healthcare Plans industry, is headquartered in USA, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Centene as an investment.
Did Centene raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Centene. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is Centene making money or losing money?
No, Centene is currently not making money — the company is losing money with a negative profit margin of -2.8%, a small loss. That means the business loses money on every dollar of revenue. The operating margin, however, is positive at 3.8% — the core business makes money; the loss comes from financing costs, taxes or one-off items. For growth stocks investing in expansion this is normal — but it raises the risk if the company does not reach break-even before its capital runs out.
Can Centene go bankrupt?
The bankruptcy risk of Centene is rated as elevated. Altman Z2 (a model for assessing financial distress) is 0.98 — that places the company in the weak zone. This is a probability based on the numbers, not a verdict — bankruptcy is not imminent. But the balance sheet is measurably weaker than average, so watch the debt, liquidity and possible capital raises. The Piotroski score (financial health 0-9, higher is better) is 7 — which is strong. Debt relative to equity is 212% (high). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Centene have a lot of debt?
Yes, Centene has elevated debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 212%. For the sundhed sector, anything above 150% counts as elevated — that raises the financial risk, especially if interest rates rise or earnings fall. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector. Can Centene service its debt? Can service its debt without problems — the interest coverage ratio (how many times earnings can cover interest payments) is 10.7x, and the company has more cash than debt (net cash).
